Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Mol Psychiatry ; 11(8): 782-6, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16619053

ABSTRACT

Although there is some evidence from twin studies that individual differences in sexual behavior are heritable, little is known about the specific molecular genetic design of human sexuality. Recently, a specific dopamine D4 receptor (DRD4) agonist was shown in rats to induce penile erection through a central mechanism. These findings prompted us to examine possible association between the well-characterized DRD4 gene and core phenotypes of human sexual behavior that included desire, arousal and function in a group of 148 nonclinical university students. We observed association between the exon 3 repeat region, and the C-521T and C-616G promoter region SNPs, with scores on scales that measure human sexual behavior. The single most common DRD4 5-locus haplotype (19%) was significantly associated with Desire, Function and Arousal scores. The current results are consistent with animal studies that show a role for dopamine and specifically the DRD4 receptor in sexual behavior and suggest that one pathway by which individual variation in human desire, arousal and function are mediated is based on allelic variants coding for differences in DRD4 receptor gene expression and protein concentrations in key brain areas.


Subject(s)
Polymorphism, Genetic , Receptors, Dopamine D4/genetics , Sexual Behavior/physiology , Sexual Dysfunction, Physiological/genetics , Sexuality/physiology , Family Health , Female , Haplotypes , Humans , Male , Phenotype , Sexual Dysfunction, Physiological/physiopathology , Surveys and Questionnaires
2.
Harefuah ; 143(6): 417-9, 462, 2004 Jun.
Article in Hebrew | MEDLINE | ID: mdl-15524098

ABSTRACT

Recent research suggests that a large number of women are dissatisfied with their sexual life due to sexual dysfunction. The accepted definitions of female sexual dysfunction are based on the human sexual response cycle described by Masters and Johnson and later elaborated by Kaplan. Their work formed the basis for the diagnostic systems of both the ICD-10 and DSM IV. Female sexual dysfunction may appear as lack of sexual desire, sexual pain, and arousal or orgasmic dysfunction. Although these problems are very common in women and more common than in males, for many years this field of interest was neglected both scientifically and clinically. In the past, only psychological and sexological forms of therapy were suggested. It is now better understood that, as in many other areas, the junction between the body and the mind, is responsible for many sex problems in women. Furthermore, multi professional team work is needed to treat these problems in order to enhance better quality of life for individuals and couples. This editorial calls for better education and research in this important field.


Subject(s)
Sexual Dysfunction, Physiological/diagnosis , Female , Humans , Libido , Male , Quality of Life , Sex Characteristics , Sexual Dysfunction, Physiological/classification
3.
Eur J Obstet Gynecol Reprod Biol ; 96(1): 111-2, 2001 May.
Article in English | MEDLINE | ID: mdl-11311772

ABSTRACT

A Muslim Bedouin couple presented with difficulty in engaging in sexual intercourse, because of primary vaginismus. The couple rejected behavioral-cognitive therapy on ethnic. Topical application of nitroglycerin ointment to the vagina enabled the couple to enjoy a satisfactory sexual relationship.


Subject(s)
Nitroglycerin/administration & dosage , Sexual Dysfunctions, Psychological/drug therapy , Vasodilator Agents/administration & dosage , Adult , Female , Humans , Male , Ointments , Pregnancy
4.
Psychopharmacology (Berl) ; 149(2): 194-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10805616

ABSTRACT

Drugs are not recognized as a standard treatment for specific phobia, despite its apparent similarities to other kinds of phobia. Reluctance on the part of patients and clinicians to see the disorder as more than normal anxiety may explain the apparent resistance to pharmacotherapy. Eleven patients fulfilling DSM-IV criteria for specific phobia were randomized to 4 weeks of double-blind treatment with placebo or paroxetine up to 20 mg/day. They were assessed weekly with the Fear Questionnaire and the Hamilton Rating Scale for Anxiety. Paroxetine showed significant superiority in reducing all measures (ANCOVA for reductions in phobia scores F=7.9, P=0.02). One out of six patients responded to placebo, compared to three out of five patients on paroxetine. This new therapeutic option (i.e. drug treatment) for specific phobia deserves further examination in a larger trial.


Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , Paroxetine/therapeutic use , Phobic Disorders/drug therapy , Double-Blind Method , Female , Humans , Male , Middle Aged , Pilot Projects
5.
Am J Psychiatry ; 156(10): 1635-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10518177

ABSTRACT

OBJECTIVE: The mechanism of action of CO2-induced anxiety is unknown and has been little studied. The authors studied healthy volunteers for the possible influence of serotonin (5-HT) on CO2-induced anxiety. METHOD: Fourteen healthy volunteers received two vital capacity inhalations each of 35% CO2 and of air, preceded once by placebo and once by the 5-HT antagonist metergoline in a double-blind, randomized crossover design. RESULTS: Mean National Institute of Mental Health self-rating anxiety subscale scores increased nonsignificantly after CO2 inhalation; this effect was significantly enhanced by the administration of metergoline. CONCLUSIONS: The authors hypothesize that 5-HT may inhibit CO2-induced anxiety, a function that is lessened by metergoline.


Subject(s)
Anxiety Disorders/chemically induced , Carbon Dioxide/pharmacology , Metergoline/pharmacology , Serotonin Antagonists/pharmacology , Administration, Inhalation , Anxiety Disorders/diagnosis , Anxiety Disorders/physiopathology , Carbon Dioxide/administration & dosage , Cross-Over Studies , Double-Blind Method , Drug Synergism , Humans , Personality Inventory/statistics & numerical data , Placebos , Serotonin/physiology
6.
Harefuah ; 136(3): 203-6, 254, 1999 Feb 01.
Article in Hebrew | MEDLINE | ID: mdl-10914198

ABSTRACT

Lately an increasing number of physicians are asked to diagnose and treat physical and mental disorders caused by alcohol abuse, a phenomena which had been quite rare in Israel until recently. Early diagnosis and efficient treatment are essential for the management of alcohol-dependent patients. Primary care physicians and hospital personnel should be more alert to the growing numbers of alcohol abusers and to their appropriate diagnosis and treatment. This article describes and summarizes the symptoms of alcohol withdrawal in general, and alcoholic delirium in particular. Problems in diagnosis and treatment are illustrated by typical cases, pointing out early clinical warning signs and suggesting some treatment guidelines.


Subject(s)
Alcohol Withdrawal Delirium/diagnosis , Alcohol Withdrawal Delirium/therapy , Adult , Alcohol Withdrawal Delirium/epidemiology , Humans , Israel/epidemiology , Male , Middle Aged
7.
Harefuah ; 135(12): 596-8, 654, 1998 Dec 15.
Article in Hebrew | MEDLINE | ID: mdl-10911490

ABSTRACT

Fluoxetine is now a well-known and often-used specific serotonin reuptake inhibitor (SSRI) and antidepressant. It has a very long active half-life, from 2-16 days. Our hypothesis was that sufficient therapeutic effectiveness would be achieved by prescribing the drug less frequently than once a day. To establish whether there is a difference between fluoxetine given daily or every 3 days, we assigned 25 outpatients with mild to moderate, acute major depressions (DSM-IV) to receive fluoxetine (20 mg), either each day or every 3 days. The study was open-labelled, using for assessment the HAM-D, GHQ-28 side-effect checklist and clinical judgment questionnaires. Follow-up lasted 6 months. Results indicated no differences in the clinical outcomes, except for slightly fewer side-effects in the study group. Although the open label design limits drawing definitive conclusions, our preliminary results provide more information, and support our hypothesis that low-dosage fluoxetine is beneficial. However, more comprehensive, double-blind studies are necessary to confirm our preliminary results.


Subject(s)
Depressive Disorder/drug therapy , Fluoxetine/therapeutic use , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Drug Administration Schedule , Female , Fluoxetine/administration & dosage , Fluoxetine/adverse effects , Humans , Male , Middle Aged , Selective Serotonin Reuptake Inhibitors/administration & dosage , Selective Serotonin Reuptake Inhibitors/adverse effects , Surveys and Questionnaires , Time Factors
8.
Harefuah ; 133(1-2): 1-2, 80, 1997 Jul.
Article in Hebrew | MEDLINE | ID: mdl-9332045

ABSTRACT

To assess the prevalence of infection and colonization of the prostate by bacteria, chip tissue samples from 166 patients undergoing retropubic prostatectomy were submitted for bacterial tissue culture. In 28 patients with an indwelling catheter before surgery, E. coli, Klebsiella, Pseudomonas and Enterobacter were the commonest species encountered, the first the most common. In only 7 patients (20%) who didn't have an indwelling catheter before operation was the culture positive. We confirmed that the longer the time the catheter was indwelling before surgery, the greater the likelihood of positive cultures. However, postoperative outcome and morbidity were not related to culture results. We conclude that even though it is worth trying to sterilize the urine and prostate before prostatectomy, the effect on the postoperative outcome is minimal when proper antimicrobial therapy is given perioperatively.


Subject(s)
Bacteria/isolation & purification , Prostate/microbiology , Prostatectomy , Antibiotic Prophylaxis , Bacteriuria , Catheters, Indwelling , Enterobacter/isolation & purification , Escherichia coli/isolation & purification , Humans , Klebsiella/isolation & purification , Male , Pseudomonas/isolation & purification , Urinary Tract Infections/prevention & control
9.
Harefuah ; 133(5-6): 188-90, 247, 1997 Sep.
Article in Hebrew | MEDLINE | ID: mdl-9461686

ABSTRACT

We present 3 cases of Capgras' syndrome-a delusional disorder in which the patient believes that 1 (or more) of his acquaintances has been replaced by an imposter who appears as a double. 2 were schizophrenics and 1 had depression with psychotic features. This syndrome is rare in our practice, but we do not know if this is due to lack of awareness of the condition, or to the possibility that it is a culture-related syndrome. We suggest that although the syndrome has lost some of it's significance, it is still worth making the diagnosis because of the medical and psychological implications this condition carries.


Subject(s)
Capgras Syndrome/diagnosis , Adult , Capgras Syndrome/complications , Capgras Syndrome/psychology , Depressive Disorder/complications , Diagnosis, Differential , Female , Humans , Male , Schizophrenia, Paranoid/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...